Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy   Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are

  Lead Investigators: Dr. Luis Paz-Ares, Dr. Luis Álvarez-Vallina.   Centre: University Hospital 12 de Octubre de Madrid, National Centre for Oncological Research (Centro Nacional de Investigaciones Oncológicas (CNIO). Context: The concept of how cancer develops has changed radically during the past few years. Tumours have ceased to be considered isolated entities that grow independently

Main Researchers: –Prof Gareth J Morgan –Dr Lorenzo Melchor The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG United Kingdom Dr Joaquín Martínez López, Unidad de Hematología, I+12 Hospital 12 de Octubre  Dr Jesús San Miguel  Dr Bruno Paiva  Flow Cytometry Unit, Clinica Universidad de Navarra; Centro de Investigaciones Médicas Aplicadas (CIMA). Universidad de Navarra (Spain)  

Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres:  CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Background Breast cancer is the most frequent type of cancer in women. It is estimated that one in 10 women may suffer from it sometime during their life. Although a large majority of

El cáncer de ovario representa el sexto tumor más frecuente dentro de la población femenina en España. Tiene una mortalidad elevada, ya que no hay métodos de detección precoz y se suele diagnosticar cuando ya se encuentra diseminado.

Principal Researcher: Dr. David Olmos y Dra. Elena Castro. Centres: Centro Nacional de Investigaciones Oncológicas – National Oncological Research Centre (CNIO), IBIMA (Instituto de biomedicina de Málaga – Málaga Biomedicine Institute ). Background: Prostate cancer is the most frequent male cancer in the Western world, and its incidence increases year by year; it is already

Principal Investigator: Dr. Joaquín Martínez Centres: 12 de Octubre University Hospital in Madrid. Timeline: 2011 – 2018. Background: Haematology or blood cell tumours are cancers which are, to a great extent, currently incurable. They are the 4th group of tumours in Spain, with almost 30,000 new cases per annum, of which only 50% are curable. They